www.economica.net/morphosis-capital-a-finalizat-li
Morphosis Capital has successfully sold its stake in Medima to Simago France SAS, achieving a 4.3x MOIC and a 31% IRR. Medima has transformed from a single clinic in Bucharest to a national imaging network with 34 clinics across Romania. The partnership with Simago aims to further enhance access to high-quality diagnostic services. Morphosis Capital's investment strategy focuses on identifying early opportunities and providing necessary capital and operational rigor. This transaction marks the third complete exit for Morphosis Capital Fund I, following previous successful sales in the healthcare sector.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.